Christine Erikstrup Hallgreen

Christine Erikstrup Hallgreen

Associate Professor

Member of:

    ORCID: 0000-0002-7916-3915

    Publication year:
    All
    1 - 8 out of 8Page size: 10
    1. 2022
    2. Published

      Flash presentation: Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Valproates

      Abtahi, S., Pajouheshnia, R., Duran-Salinas, C., Riera-Arnau, J., Gamba, M., Alsina, E., Hallgreen, Christine Erikstrup, Limoncella, G., Bartolini, C., Holthuis, E., Martin-Perez, M., Brown, J., Sturkenboom, M., Klungel, O. & Lot, O., 2022, In: Drug Safety. 45, 10, p. 1312-1313

      Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

    3. Published

      Hydroxysine initiation following drug safety advisories on cardiac arrhythmias in the UK and Canada: A longitudinal cohort study

      Morrow, R., Mintzes, B., Souverein, P., Hallgreen, Christine Erikstrup, Ahmed, B., Roughead, E., De Bruin, M. L., Kristiansen, S., Lexchin, J., Kemp-Casey, A., Sketris, I., Mangin, D., Pearson, S., Puil, L., Lopert, R., Bero, L., Gnjidic, D., Sarpatwari, A. & Dormuth, C., 2022, In: Pharmacoepidemiology and Drug Safety. 31, S2, p. 76-76 1 p.

      Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

    4. Published

      Marketing authorization pathways and clinical evidence supporting approval of orphan medicinal products in EU between January 2015 and October 2021

      Hallgreen, Christine Erikstrup, Møllebæk, Mathias & Corap, E., 2022, In: Pharmacoepidemiology and Drug Safety. 31, S2, p. 266-267

      Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

    5. Published

      Medication adherence in registration trials supporting the approval of new medicines in the European Union

      Mantila, K. M., Mol, P. G. M., Pasmooij, M., Hallgreen, Christine Erikstrup & van Boven, J. F. M., 2022, In: International Journal of Clinical Pharmacy. 44, 1, p. 279-280

      Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

    6. 2021
    7. Published

      Influence of drug safety advisories on drug utilization: An international interrupted time series and meta-analysis study

      Morrow, R. L., Mintzes, B., Souverein, P. C., De Bruin, M. L., Roughead, E. E., Lexchin, J., Kemp-Casey, A., Puil, L., Sketris, I., Mangin, D., Hallgreen, Christine Erikstrup, Pearson, S., Lopert, R., Bero, L., Ofori-Asenso, R., Gnjidic, D., Sarpatwari, A. & Dormuth, C. R., Aug 2021, In: Pharmacoepidemiology and Drug Safety. 30, S1, p. 33-34

      Research output: Contribution to journal › Conference abstract in journal › Research

    8. 2019
    9. Published

      Impact of European Benefit-Risk reassessment procedures on drug prescribing practices in Denmark

      De Bruin, M. L. (., Hallgreen, Christine Erikstrup & Andersen, Morten, Aug 2019.

      Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

    10. 2018
    11. Published

      Impact of the 2012 pharmacovigilance legislation on the harmonisation of DHPCS in the EU

      Olafsdottir, G., Bukhave, S. M., Kalligeros, G., Hallgreen, Christine Erikstrup & De Bruin, M. L., Aug 2018, p. 515-516.

      Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

    12. 2017
    13. Published

      How to Measure the Impact of Pharmacovigilance Activities on Public Health?

      Gardarsdottir, H., Kant, A., De Bruin, M. L., Hallgreen, Christine Erikstrup, Dal Pan, G. & Way, D., Aug 2017, p. 31-31.

      Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

    ID: 122745397